All news

Morgan Stanley reports a passive stake above 5% in Immunic (IMUX).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Morgan Stanley has reported a passive beneficial ownership of 704,244 shares of Immunic, Inc. (IMUX) common stock, which represents a 5.2% stake in the company. The filing indicates shared voting power over 702,419 shares and shared dispositive power over all 704,244 shares, with no sole voting or dispositive power reported.

Read original source

IMUX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.